Abstract
The following should be understood as a supplement to the excellent review of organic nitrates in Vol. 40 of this handbook which was edited in 1975 by P. Needleman. For this reason, literature older than 1974 which has already been covered by that volume is only used here when necessary. In the same way, topics such as historical background, chemistry and physicochemical properties or side effects of organic nitrates, which naturally have remained constant since then, are not referred to. Although some progress has been achieved in the difficult field of bioanalysis of organic nitrates in recent years, limited space does not allow discussion of this important matter. Sect. B in particular should be read in the context of the earlier chapter on biotransformation of organic nitrates by NEEDLEMAN (1975). Generally, special attention has been given to topics where the experimental evidence accumulated in the meantime has not confirmed the previous views of the authors of Vol. 40, such as enteral activity of organic nitrates, therapeutic value of so-called long-acting nitrates; or where our knowledge has been extended, for instance, the relation between pharmacokinetics and effect, some aspects of the mechahism of action and the development of isosorbide-5-mononitrate for the prophylactic treatment of angina pectoris. Because of the recently revived discussion of nitrate tolerance, a special section has been devoted to this problem, although some redundancy within the later sections on clinical usage was unavoidable.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abrams J (1980) Nitrate tolerance and dependence. Am Heart J 99: 113–123
Abshagen U, Demmer F (1981) Vorteile und Probleme von Retardpräparaten. Med Klin 76: 484–490
Abshagen U, Spörl-Radun S (1980) Pharmacokinetics and effect of 5-Isosorbide-mononitrate (5–ISMN) in normal man. In: Turner P, Padgham C (eds) World conference in clinical pharmacology and therapeutics. Macmillan, London, p 0377
Abshagen U, Spörl-Radun S (1981) First data on effects and pharacokinetics of isosorbide-5-mononitrate in normal man. Eur J Clin Pharmacol 19: 423–129
Abshagen U, Sporl-Radun S, Betzien G, Kaufmann B, Endele R (1981 b) Pharmakokinetik, Wirkung und Vertraglichkeit von Isosorbiddinitrat und Isosorbid-5-Mononitrat bei gesunden Versuchspersonen. Med Welt 32/14a:508–516
Abshagen U, Betzien G, Endele R, Kaufmann B, Neugebauer G (1984) Pharmacokinetics and metabolism of isosorbide dinitrate after intravenous and oral administration. Eur J Clin Pharmacol 1985 (in press)
Amende I, Simon R, Hood WP, Daniel W, Lichtlen P (1981) Direct and indirect effects of nitroglycerin on systolic and diastolic left ventricular function. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 126
Amende I, Simon R, Lichtlen PR (1983 a) Comparison of the effects of nitroglycerin, athenolol and nifedipine on left ventricular relaxation in coronary patients. J Am Coll Cardiol 1/2:680
Andersson R, Nilsson K, Wikberg J, Johansson S, Mohme-Lundholm E, Lundholm L (1975) Cyclic nucleotides and the contraction of smooth muscle. Adv Cyclic Nucleotide Res 5: 491–518
Antman E, Gunther S, Barry W (1980) Beneficial effects of intravenous glyceryl trinitrate in a case of Prinzmetal angina. Br Heart J 43: 88–91
Arce-Gomez E, Rosas J A, Barreiro LAD (1980) Antianginal effects of pentaerythritol tetranitrate. Nouv Presse Med 34: 2487–2491
Armstrong PW, Armstrong J A, Marks GS (1979) Blood levels after sublingual nitroglycerin. Circulation 59: 585–588
Aronow WS (1975) Use of nitrates as antianginal agents. In: Neddleman PH (ed) Organic nitrates. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 40, pp 163–174 )
Aronow WS (1976) Treatment of angina pectoris - pharmacologic approaches. Postgrad Med 60: 100–106
Aronow WS, Chesluk HM (1970) Sublingual isosorbide dinitrate therapy versus sublingual placebo in angina pectoris. Circulation 41: 860–874
Arsura E, Guadagnino V, Lichtstein E, Bolton S, Sanders M, Hollander G, Greengart A (1982) Methemoglobin levels produced by commonly used nitrates. Circulation 66: 11–309
Awan NA, Miller RR, Maxwell KS, Mason DT (1978) Cardiocirculatory and antianginal actions of nitroglycerin ointment - evaluation by cardiac cathestarization, forearm plethysmography and treadmill stress testing. Chest 73: 14–18
Axelsson KL, Wikberg JES, Andersson RGG (1979) Relationship between nitroglycerin, cyclic GMP and relaxation of vascular smooth muscle. Life Sci 24: 1779–1786
Axelsson KL, Andersson RGG, Wikberg JES (1981) Correlation between vascular smooth muscle relaxation and increase in cyclic GMP induced by some organic nitro esters. Acta Pharmacol Toxicol (Copenh) 49: 270–276
Axelsson KL, Andersson RGG, Wikberg JES (1982) Vascular smooth muscle relaxation by nitro compounds: reduced relaxation and cGMP elevation in tolerant vessels and reversal of tolerance by dithiothreitol. Acta Pharmacol Toxicol (Copenh) 50: 350–357
Baaske DM, Amann AH, Karnatz NN, Wong J, Wagenknecht DM, Carter JE, Stoll RG (1982) Administration set suitable for use with intravenous nitroglycerin. Am J Hosp Pharm 39: 121–122
Bache RJ (1978) Effect of nitroglycerin and arterial hypertension on myocardial blood flow following acute coronary occlusion in the dog. Circulation 57: 557–562
Bache RJ, Tockman BA (1982) Effect of nitroglycerin and nifedipine on subendocardial perfusion in the presence of a flow-limiting coronary stenosis in the awake dog. Circ Res 50: 678–687
Bache RJ, Ball RM, Cobb FR, Rembert JC, Greenfield CJ Jr (1975) Effects of nitroglycerin on transmural myocardial blood flow in the unanesthetized dog. J Clin Invest 55: 1219–1228
Bartsch W, Sponer G, Strein K, Müller-Beckmann B, Gessel B (1983) Lack of evidence for the role of prostaglandins in the vasodilating effect of organic nitrates. IRCS Med Sci 11: 67–68
Bassenge E, Holtz J, Kinadeter H, Kolin A (1981) Threshold dosages of nitroglycerin for coronary artery dilatation, afterload reduction and venous pooling in conscious dogs. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 238
Battock DJ, Levitt PW, Steele PP (1976) Effects of isosorbide dinitrate and nitroglycerin on central circulatory dynamics in coronary artery disease. Am Heart J 92: 455–458
Becker HJ, Walden G, Kaltenbach M (1976) Gibt es eine „Tachyphylaxie“bzw. Gewohnung bei der Behandlung der Angina pectoris mit Nitrokorpern. Verh Dtsch Ges Inn Med 82: 1208
Becker LC (1978) Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation 57: 1103–1110
Behrenbeck DW, Tauchert M, Hilger HH (1976) Verhalten der Koronardurchblutung und des myocardialen Sauerstoffverbrauchs bei Anderung des peripheren Gefaßwiderstandes. Verh Dtsch Ges Inn Med 82: 1172–1175
Benke T, Kraupp O, Placheta P, Stanek B, Raberger G (1980) The effect of single and repeated oral doses of isosorbide dinitrate on plasma renin activity and plasma catecholamine levels in conscious dogs. Basic Res Cardiol 75: 400–409
Bentivoglio LG, Grüntzig A (1981) Relief by intracoronary glyceryl trinitrate of coronary artery spasm resistant to sublingual route of administration. Br Heart J 46: 581–583
Bergmann G, Atkinson L, Richardson PJ, Daly K, Rothman M, Jackson G, Jewitt DE (1981) Prostacyclin: Haemodynamic and metabolic effects in patients with coronary artery disease. Lancet 1: 569–572
Bernstein LM, Ivy AC (1955) Inositol and mannitol hexanitrates in hypertension management. Circulation 12: 353–360
Biamino G, Noring J (1977) Wirkung von Nitraten auf das Verhalten der mechanischen und elektrischen Aktivitat der Aorta und Portalvene von Ratten. Verh Dtsch Ges Kreislaufforseh 43: 416
Blasini R, Briigmann U, Mannes A, Froer KL, Hall D, Rudolph W (1980) Wirksamkeit von Isosorbiddinitrat in retardierter Form bei Langzeitbehandlung. Herz 5: 298–305
Blasini R, Froer KL, Bliimel G, Rudolph W (1982) Wirkungsverlust von Isosorbiddinitrat bei Langzeitbehandlung der chronischen Herzinsufflzienz. Herz 7: 250–258
Blumenthal HP, Fung HL, McNiff EF, Yap SK (1977) Plasma nitroglycerin levels after sublingual, oral and topical administration. Br J Clin Pharmacol 4: 241–242
Bohme E, Graf H, Schultz G (1978) Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. Adv Cyclic Nucleotide Res 9: 131–143
Bogaert MG (1968) Tolerance towards glyceryl trinitrate (trinitrin) in rabbits. Arch Int PharmacodynTher 172: 228–230
Bogaert MG, de Schaepdryver AF (1968) Tolerance towards glyceryl trinitrate (trinitrin) in dogs. Arch Int Pharmacodyn Ther 171: 221–224
Bogaert MG, Rosseel MT (1972) Vascular effects of the dinitrate and mononitrate esters of isosorbide, isomannide and isoidide. Naunyn Schmiedebergs Arch Pharmacol 275:339–342 Bogaert MG, Rosseel MT (1980) Plasma levels of isosorbide dinitrate and the isosorbide mononitrates after increasing doses of a retard preparation of isosorbide dinitrate. Nouv Presse Med 9: 2423–2427
Bogaert MG, Rosseel MT, Boelaert J, Daneels R (1981) Fate of isosorbide dinitrate and mononitrates in patients with renal failure. Eur J Clin Pharmacol 21: 13–16
Bonoron–Adele S, Tariosse L, Bricaud H, Besse P (1981) Demonstration of a real inotropic effect of nitrites on myocardial contractility during anoxia and reoxygenation: attempt to determine action site with the contribution of calcium antagonistic compounds. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 157
Borer JS, Bacharach SL, Green MV, Kent KM, Johnson GS, Epstein SE (1978) Effect of nitroglycerin on exercise–induced abnormalities of left ventricular regional function and ejection fraction in coronary artery disease. Circulation 57: 314–320
Borow KM, Spann JF, Coulson RL (1981) The direct myocardial energetic response to nitroglycerin in the rabbit heart. J Pharmacol Exp Ther 217: 566–571
Bossi M, Cataldo G, Colombo A, Fiorista F, Gentili D, Pirelli S (1977) Sublingual isosorbide dinitrate–induced severe hypotension, bradycardia and prelypothymia in patients with acute myocardial infarction. G Ital Cardiol 7: 922–926
Braughler JM (1981) Dissociation of increases in cyclic GMP from relaxation of arterial smooth muscle. Eur J Pharmacol 69: 503–505
Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT (1981) The mechanism of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation 64: 1089–1097
Brüggemann Th, Peslin K, Biamino G (1983) Erfassung von linksventrikularen Funktionsanderungen unter Nitraten bei koronarer Herzkrankheit mittels einer KG–getriggerten Szintillationssonde (Abstr). Z Kardiol 72 [Suppl 1]: 93, 330
Brunner D, Weisbord J, Meshulam N, Margulis S (1980) Langzeitwirkung und Dauertherapie mit kutan apphziertem Isosorbiddinitrat. MMW 122: 801–806
Brunner D, Weisbord J, Meshulam N, Margulis S (1981) Unchanged efficacy of acute sublingual nitrate compounds during long–term treatment with percutaneously applied isosorbide dinitrate ointment. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 100
Bruyneel K, Rosseel MT, Bogaert MG (1982) Plasma concentrations of isosorbide dinitrate and mononitrates after acute and chronic oral administration of isosorbide dinitrate in man. Arzneimittelforsch 32: 769–772
Bussmann WD, Lohner J, Kaltenbach M (1977) Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction. Am J Cardiol 39: 91–96
Bussmann WD, Neumann K, Kaltenbach M (1980) Die Wirkung von Nitroglycerin auf die ventrikulare Extrasystolie beim frischen Herzinfarkt. Dtsch Med Wochenschr 105: 369–373
Buxton A, Goldberg S, Hirshfeld JW, Wilson J, Mann T, Williams DO, Overlie P, Oliva P (1980) Refractory ergonovine–induced coronary vasospasm: importance of intracoronary nitroglycerin. Am J Cardiol 46: 329–334
Capurro NL, Kent KM, Epstein SE (1976) Effects of intracoronary and intravenous nitroglycerin on coronary collateral function. J Pharmacol Exp Ther 199: 262–269
Capurro NL, Kent KM, Epstein SE (1977) Comparison of nitroglycerin–, nitroprussideand
phentolamine–induced changes in coronary collateral function in dogs. J Clin Invest 60:295–301
Carmichael P, Lieben PJ (1963) Sudden death in explosives workers. Arch Environ Health 7: 424–439
Carr LJ (1975) Pharmacological properties. In: Needleman PH (ed) Organic nitrates. Springer, Berlin Heidelberg New York, p 39 (Handbook of experimental pharmacology, vol 40 )
Cartheuser DF, Komarek J (1979) Effects of nitroglycerin on the circulatory system, myocardial dynamics and left ventricular oxygen consumption in the anaesthetized beagledog. Basic Res Cardiol 74: 161–176
Chasseaud LF, Taylor T (1980) Plasma concentrations and comparative bioavailability of isosorbide dinitrate after sublingual, oral or cutaneous doses to human subjects. In: Rudolph W, Schrey A (eds) Nitrate II. Urban and Schwarzenberg, Munich, p 22
Chasseaud LF, Taylor T (1981) Pharmacokinetics of isosor bide mononitrates in human subjects. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 47
Chausseaud LF, Down WH, Grundy RK (1975) Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects. Eur J Clin Pharmacol 8:157–160 Chen HI, Chen SJ, Cheng CF (1979) Direct and reflex effects of nitroglycerin on the blood volume distribution, evaluated by regional weighing in the cat. J Pharm Pharmacol 31: 810–813
Chen HI, Yeh FC, Weber HO (1981) Direct effects of nitroglycerin on the resistance, exchange and capacitance functions of the canine intestinal vasculature. J Pharmacol Exp Ther 218: 497–503
Cheng TO (1971) Hypotension during coronary arteriography. Chest 60: 618
Cohen MV, Sonnenblick EH, Kirk ES (1976) Comparative effects of nitroglycerin and isosorbide dinitrate on coronary collateral vessels and ischemic myocardium in dogs. Am J Cardiol 37: 244–249
Cohn PF, Braunwald E (1980) Chronic coronary artery disease. In: Braunwald (ed) Heart disease. Saunders, Philadelphia, p 1414
Cohn PF, Maddox D, Holman BL, Markis JE, Adams DF, See JR (1977) Effect of sublingual administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am J Cardiol 39: 672–678
Cole SL, Kaye H (1975) Antianginal effects of oral, controlled–released nitroglycerin (GNT) in patients with coronary artery disease (CAD): Double–blind randomized, multiple crossover study. Clin Res 23: 177A
Colfer H, Stetson P, Lucchesi BR, Wagner J, Pitt B (1982) The nitroglycerin polymer gel matrix system: A new method for administering nitroglycerin evaluated with plasma nitroglycerin levels. J Cardiovasc Pharmacol 4: 521–525
Come PC, Pitt B (1976) Nitroglycerin–induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation 54: 624–628
Commarato MA, Winbury MM, Kaplan HR (1973) Glyceryl trinitrate and pentrinitrol (pentaerythritol trinitrate): Comparative cardiovascular effects in dog, cat and rat by different routes of administration. J Pharmacol Exp Ther 187: 300–307
Conti CR, Curry RC, Christie LG, Mehta J, Pepine CJ (1979) Initial medical and surgical management of unstable angina pectoris. Clin Cardiol 2: 311–316
Cossum PA, Galbraith AJ, Roberts MS, Boyd GW (1978) Loss of nitroglycerin from intravenous sets. Lancet 2: 349–350
Cote DD, Torchia MG (1982) Nitroglycerin adsorption to polyvinylchloride, seriously interferes with its clinical use. Anesth Analg (Cleve) 61: 541 — 543
Cowan C, Duran PVM, Corsini G, Goldschlager N, Bing RJ (1969) The effects of nitroglycerin on myocardial blood flow in man, measured by coincidence counting and bolus injections of 84 rubidium. Am J Cardiol 24: 154–160
Crandall LA, Leake CD, Loevenhart AS, Muehlberger CW (1931) Acquired tolerance to and cross tolerance between the nitrous and nitric acid esters and sodium nitrate in man. J Pharmacol Exp Ther 41: 103–119
Craven PA, DeRubertis FR (1978) Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl–heme comples in enzyme activation. J Biol Chem 253: 8433–8443
Crean PA, Ribeiro P, Crea F, Davies GJ, Ratcliffe D, Maseri A (1983) Continuous transdermal nitroglycerin administration in the treatment of chronic angina pectoris. Circulation 68: 111–405 (Abstract)
Crew MC, Melgar MD, DiCarlo FJ (1975) Pentaerythritol tetranitrate and metabolites in rat plasma. J Pharmacol Exp Ther 192: 218–223
Cyran J (1980) Die Therapie des akuten Myocardinfarktes. Internist (Berlin) 21: 675–684
Danahy DT, Aronow WS (1977) Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use. Circulation 56: 205–212
Danahy DT, Burwell DT, Aronow WS, Prakash R (1977) Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate. Circulation 55: 381–387
Dashkoff N, Roland JMA, Varghese PJ, Pitt B (1976) Effect of nitroglycerin on ventricular fibrillation threshold of non–ischemic myocardium. Am J Cardiol 38: 184–188
Dauwe F, Affaki G, Waters DD, Theroux P, Mizgala HF (1979) Intravenous nitroglycerin in refractory unstable angina. Am J Cardiol 43: 416
Davidov ME (1981) Cutaneous administration of nitroglycerin in patients with angina pectoris. Angiology 32: 16–20
Davidov ME, Mroczek WJ (1976) The effect of nitroglycerin ointment on the exercise capacity in patients with angina pectoris. Angiology 27: 205–211
Davidov ME, Mroczek WJ (1977) Effect of sustained release nitroglycerin capsules on anginal frequency and exercise capacity: A double–blind evaluation. Angiology 28: 181–189
Davidson IWF, Miller HS Jr, DiCarlo FJ (1970) Absorption, excretion and metabolism of pentaerythritol tetranitrate by humans. J Pharmacol Exp Ther 175: 42–50
Dexter D (1982) New topical nitroglycerin preparations. Am J Nurs 82: 643
DiCarlo FJ (1975) Nitroglycerin revisited: chemistry, biochemistry, interactions. Drug Metab Rev 4: 1–38
DiCarlo FJ, Crew MC, Brusco LS, Davidson IWF (1977) Metabolism of pentraerythritol trinitrate. Clin Pharmacol Ther 22: 309–315
Distante A, Maseri A, Severi S, Biagini A, Chierchia S (1979) Management of vasospastic angina at rest with continuous infusion of isosorbide dinitrate. Am J Cardiol 44: 533–539
Distante A, L’Abbate A, Palombo C, Michelassi C, Rovai D, Morales MA, Sabino F, Moscarelli E, Lombardi M, Maseri A (1981) May prolonged high doses of nitrates cause tolerance? Preliminary results on the response to an additional dose by infusion. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, pp 82–90
Donaldson RM, Rickards AF (1981) The effect of nitrates on pressure–time indices and coronary graft blood flow in man. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 209
Down WH, Chasseaud LF, Grundy RK (1974) Biotransformation of isosorbide dinitrate in humans. J Pharm Sci 63: 1147–1149
Doyle E, Chasseaud LF (1981) Pharmacokinetics of isosorbide dinitrate in rhesus monkey, cynomolgus monkey and baboon. J Pharm Sci 70: 1270–1272
Dumeshil JG, Ritman EL, Davis GD, Gau GT, Rutherford BD, Frye RL (1975) Regional left ventricular wall dynamics before and after sublingual administration of nitroglycerin. Am J Cardiol 36: 419–425
Dunham EW, Haddox MK, Goldberg ND (1974) Alteration of vein cyclic 3’:5’–nucleotide concentrations during changes in contractility. Proc Natl Acad Sci USA 71: 815–819
Durairaj M, Narayanan GR, Kher HL (1979) Nitroglycerine on cardiac conduction. Indian Heart J 31: 363–366
Ebright GE (1914) The effect of nitroglycerin on those engaged in its manufacture. JAMA 62: 201–202
Engel HJ, Lichtlen PR (1981) Beneficial enhancement of coronary blood flow by nifedipine. Comparison with nitroglycerin and beta blocking agents. Am J Med 71: 658–666
Ertl G, Simm F, Wichmann J, Fuchs M, Lochner W (1979) The dependence of collateral blood flow on regional vascular resistances. Naunyn Schmiedebergs Arch Pharmacol 308: 265–272
Fallen EL, Cairns JA, Stolberg HO, Tanser PH (1978) Relief of coronary artery spasm by nitroglycerin: Time–dependent variability in drug action. Cathet Cardiovasc Diagn 4: 237–247
Fam WM, McGregor M (1964) Effect of coronary vasodilator drugs on retrograde flow in areas of myocardial ischemia. Circ Res 15: 355–365
Feigen LP, Chapnick BM, Flemming JE, Kadowitz PJ (1978) Prostaglandins: renal vascular responses to bradykinin, histamine and nitroglycerine. Am J Physiol 234: H496–H502
Feldman RL, Conti ER (1981) Editorial: Relief of myocardial ischemia with nitroglycerin: What is the mechanism? Circulation 64: 1098–1100
Feldman RL, Pepine CJ, Curry RC, Conti CR (1979) Coronary arterial responses to graded doses of nitroglycerin. Am J Cardiol 43: 91–97
Feldman RL, Pepine CJ, Conti CR (1981) Magnitude of dilatation of large and small coronary arteries by nitroglycerin. Circulation 64: 324 — 333
Feldman RL, Marx JD, Pepine CJ, Conti CR (1982) Analysis of coronary responses to various doses of intracoronary nitroglycerin. Circulation 66: 321–327
Fermum R, Klinner U, Meisel P (1976) Versuche zum Wirkungsmechanismus von Gefaßspasmolytika. I. Wirkung von Nitroprussid–Natrium, Nitroglyzerin, Premylanin und Verapamil an der arretierten Kalzium–induzierten Kontraktor isolierter Koronararterien. Acta Biol Med Ger 35: 1347–1358
Ferrer MI, Bradley SE, Wheller HO, Enson Y, Preisig R, Brickner PW, Conroy RJ, Harvey RM (1966) Some effects of nitroglycerin upon the splanchnic, pulmonary and systemic circulations. Circulation 33: 357–373
Fibuch EE, Cecil WT, Reed WA (1979) Methemoglobinemia associated with organic nitrate therapy. Anesth Analg (Cleve) 58: 521–523
Flaherty JT (1982) Intravenous nitroglycerin. Johns Hopkins Med J 151: 36–40
Fleckenstein A, Nakayama K, Fleckenstein–Griin G, Byon YK (1975) Interactions of vasoactive ions and drugs with Ca–dependent excitation–contraction coupling of vascular smooth muscle. In: Carafoli E, Clementi F, Drabikowski W, Margreth A (eds) Calcium transport in contraction and secretion. Elsevier/North–Holland, Amsterdam, Oxford New York, pp 555–566
Forster W (1980 a) Significance of prostaglandins and thromboxane A2 for the mode of action of cardiovascular drugs. Adv Prostaglandin Thromboxane Res 7:609–618
Forster W (1980 b) Effect of various agents on prostaglandin biosynthesis and the antiaggregatory effect. Acta Med Scand [Suppl] 642:35–46
Franciosa JA, Cohn JN (1980) Sustained hemodynamic effects without tolerance during long–term isosorbide dinitrate treatment of chronic left venticular failure. Am J Cardiol 45: 648–654
Freeman WR, Peter T, Mandel WJ (1981) Verapamil therapy in variant angina pectoris refractory to nitrates. Am Heart J 102: 358–362
Fremont RE (1961) Controlled observations on clinical efficacy of isosorbide dinitrate. Geriatrics 16: 520–529
Friedman PL, Brown EJ, Gunther S, Alexander RW, Barry WH, Mudge GH Jr, Grossmann W (1981) Coronary vasoconstrictor effect of indomethacin in patients with coronaryartery disease. N Engl J Med 305: 1171–1175
Frydman A, Levenson J, Simon A, Safar M, Bieder A, Bertharion J, Gaillor J (1982) Pharmacocinetique du dinitrate d’isosorbide. Nouv Presse Med 11: 2049–2056
Fung HL, Parker JO (1983) Prolonged plasma half–life after oral isosorbide dinitrate in patients with angina pectoris. Br J Clin Pharmacol 15: 746–748
Fung HL, Morrison RA, Kamiya A ( 1981 b) Uptake and interaction of organic nitrates at blood vessel site. In: Kaltenbach M, Bussmann WD, Schrey A (eds) Mononitrat–Workshop Kronberg 1980. Wolf, Munich, p 29
Fung HL, Sutton SC, Kamiya A (1984) Blood vessel uptake and metabolism of organic nitrates in the rat. J Pharm Exp Ther 228: 334–341
Gagnon RM, Lemire J, Beaudet R (1980) Intravenous use of nitroglycerin to control servere ventricular arrhythmias in unstable angina. Can Med Assoc J 123: 1131–1133
Ganz W, Marcus HS (1972) Failure of intracoronary nitroglycerin to elleviate pacing–induced angina. Circulation 46: 880–889
Ganz W, Marcus HS (1973) Changes in myocardial oxygen consumption during relief of pacing–induced angina by nitroglycerin. Am J Cardiol 31: 133
Geigenberger A, Degen J, Maier–Lenz H (1982) Vergleichende Pharmakokinetik und Bioverfügbarkeit von Isosorbiddinitrat und seiner Metaboliten 5– und 2–Isosorbidmononitrat aus zwei Retardpraparaten. Arzneimittel Forsch 32: 1138–1140
Georgopoulos AJ, Markis A, Georgiadis H (1982) Therapeutic efficacy of a new transdermal system containing nitroglycerin in patients with angina pectoris. Eur J Clin Pharmacol 22: 481
Georgopoulos AJ, Markis A, Georgiadis H (1984) Therapeutische Studien mit Nitroderm–TTS. In: Bussmann W-D, Taylor SH (eds) Nitroderm–Neue Horizonte in der Nitrattherapie. Medizin–Verlag, Munchen, pp 23–32
Gerson JI, Allen FB, Seitzer JL, Parker FB Jr, Markowitz AH (1982) Arterial and venous dilation by nitroprusside and nitroglycerin–is there a difference? Anesth Analg (Cleve) 61: 256–260
Gerzer R, Bohme E, Hofmann F, Schultz G (1981) Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett 132: 71–74
Gerzer R, Radany EW, Garbers DL (1982) The separation of the heme and apoheme forms of soluble guanylate cyclase. Biochem Biophys Res Commun 108: 678–686
Gibson GR, Hunter JB, Raabe DS, Manjoney DL, Ittleman FP (1982) Methemoglobinemia produced by high–dose intravenous nitroglycerin. Ann Intern Med 96: 615–616
Ginsburg R, Lamb IH, Schroeder JS, Hu M, Harrison DC (1982) Randomized doubleblind comparison of nifedipine and isosorbide dinitrate therapy in variant angina pectoris due to coronary artery spasm. Am Heart J 103: 44–48
Gladigau V, Neurath G, Diinger M, Schnelle K, Johnson KI (1981) Plasma levels of isosorbide dinitrate and its main metabolites following oral administration of two sustained release formulations in normal man. Arzneimittelforsch 31: 835–840
Glancy DL, Richter MA, Ellis EV, Johnson W (1977) Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease. Am J Med 62: 39–46
Gmeiner R (1974) Effect of nitroglycerin on the mechanical and metabolise performance of the isolated aerobic and hypoxicrat heart. Eur J Cardiol 2: 47–54
Goldstein RE, Rosing DR, Redwood D, Beiser GD, Epstein SE (1971) Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin. Circulation
Gorman MW, Sparks HV Jr (1980) Nitroglycerin causes vasodilatation within ischaemic myocardium. Cardiovasc Res 14: 515–521
Gould L, Reddy CVR, Chua W, Swamy CRN, Dorismond JC (1976) The effect of nitroglycerin on atrioventricular conduction in man. Am J Med 60: 922–927
Gould L, Reddy CVR, Chua W, Swamy CRN, Dorismond JC (1977) Electrophysiologic properties of nitroglycerin in man. Am Heart J 94: 341–348
Greenberg H, Dwyer EM Jr, Jameson AG, Pinkernell BH (1975) Effects of nitroglycerin on the major determinants of myocardial oxygen consumption. An angiographic and hemodynamic assessment. Am J Cardiol 36: 426–432
Gross GJ, Hardman AF (1975) Alteration in oxyhemoglobin equilibrium and myocardial oxygen consumption (MV02) by nitroglycerin ( GTN ). J Pharmacol Exp Ther 193: 346–355
Gross GJ, Waltier DC (1977) Intracoronary versus intravenous nitroglycerin on the transmural distribution of coronary blood flow. Cardiovasc Res 11: 499–506
Gross GJ, Diemer MJ, Waltier DC, Hardman HF (1981) Relaxation of potassium–depolarized canine, bovine and procine large coronary arteries by nitroglycerin, chromonar and two dihydropyridine calcium antagonists. Gen Pharmacol 12: 199–204
Groves BM (1977) Variant angina: An electrocardiographic and arteriographic spectrum produced by coronary artery spasm. Curr Probl Cardiol 2: 62–63
Gruetter CA, Barry BK, McNamara DB, Griittner DY, Kadowitz PJ, Ignarro LJ (1979) Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res 5: 211–224
Gruetter CA, Barry BK, McNamara DB, Kadowitz PJ, Ignarro LJ ( 1980 a) Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N’-nitrosonornicotine and nitric oxide. J Pharmacol Exp Ther 214: 9–15
Gruetter CA, Kadowitz PJ, Ignarro LJ (1981 b) Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amy nitrite. Can
J Physiol Pharmacol 59:150–156
Gruetter DY, Griitter CA, Barry BK, Baricos WH, Hyman AL, Kadowitz PJ, Ignarro LJ (1980) Activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside, and nitrosoguanidine - inhibition by calcium, lanthanum, and other cations, enhancement by thiols. Biochem Pharmacol 29: 2943–2950
Grüntzig A (1980) Collateral pressure distal to coronary obstructions - Influence of nitrates. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Sprnger, Berlin Heidelberg New York, p 192
Guthenberg C and Mannervik B (1979) Purification of glutathione–s–transferase from rat lung by affinity chromatography. Biochem Biophys Res Commun 86: 1304–1310
Habig WH, Kamisaka K, Kettey JN, Pabst MJ, Arias IM, Jakoby WB (1976) The human hepatic glutathione S-transferase. In: Arias IM, Jakoby WB (eds) Glutathione: Metabolism and function. Raven, New York, pp 225–237
Halkin H, Almog S, Friedman E (1979) Serum concentrations of isosorbide dinitrate produced by a sustained-release capsule. Israel J Med Sci 15: 448–450
Hannemann RE, Erb RJ, Stoltman WP, Bronson EC, Williams EJ, Long RA, Hull JH, Starbuck RR (1981) Digital plethysmography for assessing erythrityl tetranitrate bioavailability. Clin Pharmacol Ther 29: 35–39
Hans P, Paris P, Mathot F (1982) Methods and devices–Intravenous nitroglycerin perfusion techniques - Clinical implications. Intensive Care Med 8: 93–95
Hardarson T, Wright KE (1976) Effect of sublingual nitroglycerin on cardiac performance in patients with coronary artery disease and non-dyskinetic left ventricular contraction. Br Heart J 38: 1272–1277
Harder DR, Belardinelli L, Sperelakis N, Rubio R, Berne RM (1979) Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries. Circ Res 44: 176–182
Hausler G, Thorens S (1976) The pharmacology of vasoactive antihypertensives. In: Bevan JA, Brunstock G, Maxwell RA, Johansson B, Nedergaard OA (eds) Vascular neuroeffector mechanisms. Karger, Basel, pp 232–241
Heeg E, Langer A (1981) Vergleichende Untersuchungen von Isosorbiddinitrat, Isosorbid-5-Mononitrat und Natriumnitrit an isolierten Gefaßpraparaten. Med Welt 32: 497–498
Heinzow B, Ziegler A (1981) Comparison of the effects of nitroglycerin administered to rats by different routes. J Cardiovasc Pharmacol 3: 573–580
Hendricks AA, William G (1979) Contact dermatitis due to nitroglycerin ointment. Arch Dermatol 115: 853–855
Herman AG, Bogaert MG (1971) Organic nitrates. Tolerance at the level of the vascular smoth muscle. Arch Int Pharmacodyn Ther 192: 200–202
Hill NS, Antman EM, Green LH, Alpert JS (1981) Intravenous Nitroglycerin - A review of pharmacology, indications, therapeutic effects and complications. Chest 9: 79–76
Hillis LD, Braunwald E (1978) Coronary-artery spasm. N Engl J Med 299: 695–702
Himori N, Imai Y, Taira N (1977) Positive inotropic action of glyceryl trinitrate as observed in the blood-perfused papillary muscle preparation of the dog heart. Clin Exp Pharmacol Physiol 4: 257–262
Hirsch PD, Hillis LD, Campbell WB, Firth BG, Willerson JT (1981) Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 304: 685–691
Hirshleifer I (1973) Peripheral hemodynamic effects of oral controlled-release nitroglycerin (nitrong) in man. Curr Ther Res 15: 158–164
Hirzel HO, Stoffel P, Krayenbuehl HP (1983) Does isosorbide-5-mononitrate influence left ventricular isovolumic relaxation? Z Kardiol 72, Suppl 3: 66–70
Hodgson JR, Lee CC (1975) Trinitroglycerol metabolism: Denization and glucuronide formation in the rat. Toxicol Appl Pharmacol 34: 449–455
Hodgson JR, Glennon JP, Dacre JC, Lee CC (1977) Metabolism and disposition of isomers of dinitro- and mononitroglycerol in the rat. Toxicol Appl Pharmacol 40: 65–70
Hoelzer M, Schaal SF, Leier CV (1981) Electrophysiologic and antiarrhythmic effects of nitroglycerin in man. J Cardiovasc Pharmacol 3: 917–923
Hoffmann JIE, Buchberg GD (1976) Transmural variation in myocardial perfusion. In: Yu PN, Goodwin JF (eds) Progress in cardiology. Lea and Febiger, Philadelphia, p 38
Hogstedt C, Andersson K (1979) A cohort study on mortality among dynamite workers. JOM 21: 553–556
Holtz J, Giesler M, Bassenge E (1983) Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo: indirect, flow-dependent, endothelium-mediated dilation and direct smooth muscle relaxation. Z Kardiol 62 [Suppl 3]: 98–106
Hood WR, Amende I, Simon R, Lichtlen PR (1980) The effects of intracoronary nitroglycerin on left ventricular systolic and diastolic function in man. Circulation 61: 1098–1140
Horhota ST, Fung HL (1978) Site dependence for topical absorption of nitroglycerin in rats. J Pharm Sci 67: 1345–1346
Horne MK, Waterman MR, Simon LM, Garriott JC, Foerster EH (1979) Methemoglobinemia from sniffing butyl nitrite. Ann Intern Med 91: 417–418
Howe BB, Weiss HR, Wilkes SB, Winbury MM (1975) Pentaerythritol trinitrate and glyceryl trinitrate on intramyocardial oxygenation and perfusion in the dog. Krogh analyses of transmural metabolism. Clin Exp Pharmacol Physiol 2: 529–540
Ignarro LJ, Gruetter CA (1980) Requirements of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite. Possible involvement of Snitrosothiols. Biochim Biophys Acta 631: 221–231
Ignarro LJ, Barry BK, Gruetter DY, Edwards JC, Ohlstein EH, Gruetter CA, Baricos WH (1980a) Guanylate cyclase activation by nitroprusside and nitrosoguanidine is related to formation of S-Nitrosothiol intermediates. Biochem Biophys Res Commun 94: 93–100
Ignarro LJ, Barry BK, Gruetter DY, Ohlstein EH, Gruetter CA, Kadowitz PJ, Baricos WH (1981a) Selective alterations in responsivenese of guanylate cyclase to activation by nitroso compounds during enzyme purification. Biochim Biophys Acta 673: 394–407
Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA (1981c) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218: 739–749
Imai S, Kitagawa T (1981) A comparison of the differential effects of nitroglycerin, nifedipine and papaverine on contractures induced in vascular and intestinal smooth muscle by potassium and lanthanum. Jpn J Pharmacol 31: 193–199
Imhof PR, Ott B, Frankhauser P, Chu LC, Hodler J (1980) Difference in nitroglycerin dose- response in the venous and arterial beds. Eur J Clin Pharmacol 18: 455–460
Imhof PR, Ott B, Weiss A, Chu LC, Chasseaud LF (1981) Plasma concentrations and hemodynamic effects of percutaneously administered nitroglycerin and isosorbide dinitrate in healthy volunteers. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 66
Imhof PR, Sieber A, Hodler J, Müller P, Ott B, Frankhauser P, Chu LC, Geradin A (1982) Plasma concentrations and hemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers. Eur J Clin Pharmacol 23: 99
Isbarry J, Doering W, Wauer B, Greding H, Konig E (1981) Hamodynamische Veranderungen in Ruhe und wahrend Belastung nach 20 mg Isosorbid-5-Mononitrat bei Patiente mit koronarer Herzerkrankung. Med Welt 32: 530–534
Ito Y, Kitamura K, Kuriyama H (1980) Actions of nitroglycerine on the membrane and mechanical properties of smooth muscles of the coronary artery of the pig. Br J Pharmacol 70: 197–204
Jaffe JH (1980) The pharmacological basis of therapeutics, Drug addiction and drug abuse. In: Goodman LS, Gilman A (eds) Macmillan, New York, pp 535–544
Janis RA, Diamond J (1979) Relationship between cyclic nucleotide levels and drug-induced relaxation of smooth muscle. J Pharmacol Exp Ther 211: 480–484
Jansen WC, Tauchert M, Niehues B, Hombach V, Behrenbeck DW (1980) Koronardurchblutung und myocardialer Sauerstoffverbrauch vor und nach Einnahme von 0,8 mg Nitroglyzerin im Vergleich zu Atenolol. Med Welt 31: 1313–1316
Jansen WC, Hombach V, Niehus B, Tauchert M, Behrenbeck DW, Hilger HH (1981) Myocardial oxygen consumption and coronary blood flow at rest and during exercice after application of nitroglycerin. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJ (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 427
Jansen WC, Osterspey A, Fuchs M, Tauchert M, Schell U, Weste S, Hombach V (1982) Hamodynamische Wirkung von 20 mg und 50 mg 5-Isosorbidmononitrat unter acuter und chronischer Therapie. Med Welt 33 /48: 1756–1762
Jett GK, Dengle SK, Piatt MR, Eberhard RC, Willerson JT, Watson JT (1978) The influence of isosorbide dinitrate on regional myocardial blood flow during acute coronary occlusion in the dog. Cardiovasc Res 12: 497–506
Johnson KI, Gladigau V, Schnelle K (1981) Relationship between the pharmacodynamics and pharmacokinetics of two oral sustained-release formulations of isosorbide dinitrate in normal man. Arzneimittelforsch 31: 1026–1029
Kadowitz PJ, Nandiwada P, Griitter CA (1981) Pulmonary vasodilator responses to nitroprusside and nitroglycerin in the dog. J Clin Invest 67: 893–902
Karashima T (1980) Actions of nitroglycerine on smooth muscles of the guinea-pig and rat protal veins. Br J Pharmacol 69: 489–497
Karsh DL, Umbach RE, Cohen LS, Langou RA (1978) Prolonged benefit of nitroglycerin ointment on exercise tolerance in patients with angina pectoris. Am Heart J 96: 587–595
Kasparian H, Wiener L, Duca PR, Gottlieb RS, Brest AN (1975) Comparative hemodynamic effects of placebo and oral isosorbide dinitrate in patients with significant coronary artery disease. Am Heart J 90: 68–74
Kattus AA, Alvaro AB (1975) Effectiveness of isosorbide dinitrate and nitroglycerin in relieving angina pectoris during uninterrupted exercise. Chest 67: 640–646
Kattus AA, Alvaro AB, Zohman LR, Coulson AH (1979) Comparison of placebo, nitroglycerin and isosorbide dinitrate for effectiveness of relief of angina and duration of action. Chest 75: 17–23
Kaverina NV, Chumburidze VB (1979) Antianginal drugs. Pharmacol Ther 4: 109–153
Keith RA, Burkman AM, Sokoloski TD, Fertel RH (1982) Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharmacol Exp Ther 221: 525–531
Kent KM, Smith ER, Redwood DR, Epstein SE (1974) Beneficial electro–physiologic effects of nitroglycerin during acute myocardial infarction. Am J Cardiol 33: 513–516
Khan AH, Carleton RA (1981) Nitroglycerin–induced hypotension and bradycardia. Arch Intern Med 141: 984
Klaus AP, Zaret BL, Pitt BL, Ross RS (1973) Comparative evaluation of sublingual longacting nitrates. Circulation 48: 519
Klein RC, Grehl TM, Stengert KB, Mason DT (1981) Evaluation of the effects of systemic
nitroglycerin on perfusion of ischemic myocardium in coronary heart disease assessed intraoperatively by antegrade blood flow through intact saphenous vein bypass grafts. Am Heart J 101:292–299
Klock JC (1975) Non-occlusive coronary disease after chronic exposure to nitrate: Evidences for physiologic nitrate dependence. Am Heart J 89: 510–513
Knoebel SB, Rasmussen S, Noble RJ, Mihalick MJ (1975) Nitroglycerin and premature ventricular complexes in myocardial infarction. Br Heart J 37: 1064–1068
Kobayashi A, Ogawa K (1979) Effects of coronary vasodilator on cyclic nucleotides. - The concentrations of cyclic AMP and cyclic GMP in canine coronary artery and left ventricular muscle following the administration of various coronary vasodilators Jpn Circ J 43: 6–54
Kobayashi A, Suzuki Y, Kamikawa T, Hayashi H, Yamazaki N (1980) The effects of nitroglycerin on cyclic nucleotides in the coronary artery in vivo. Life Sci 27: 1679–1685
Kober G, Strohm WD (1982) Rontgenologischer und sonographischer Nachweis einer dilatierenden Wirkung von Nitroglyzerin auf pulmonale und abdominale Venen. Inn Med 9: 305–312
Kober G, GroBmann R, Schulz W, Kaltenbach M (1981) Durchmesseranderungen der kleinen arteriellen und venosen Lungengefaße unter Nitroglycerin. Z Kardiol 70: 547–554
Kosters W, Klotschkoff P, Abshagen U (1981) Pharmakokinetik von Isosorbid-5-Mononitrat bei Patienten mit fortgeschrittener Niereninsuffizienz. Med Welt 32: 521–523
Kopman EA, Weybrandt GR, Bauer S, Ferguson TB (1978) Arterial hypoxemia following the administration of sublingual nitroglycerin. Am Heart J 96: 444–447
Korth M (1975) Influence of glyceryl trinitrate on force of contraction and action potential of guinea-pig myocardium. Naunyn Schmiedebergs Arch Pharmacol 287: 329–437
Kreye VAW (1978) Organic nitrates, Sodium nitroprusside and vasodilation. In: Vanhoutte PM, Leusen I (eds) Mechanism of vasodilation. Karger, Basle, pp 158–164
Kreye VAW (1981) Role of the membrane potential in the function of vascular smooth muscle. In: Yanhoutte PM, Leusen I (eds) Vasodilatation. Raven, New York, pp 299–305
Kreye VAW, Liith JB (1976) Effect of sodium nitroprusside, temperature and calcium withdrawal on the relaxation speed of vascular smooth muscle. In: Betz E (ed) Ionic actions on vascular smooth muscle. Springer, Berlin Heidelberg New York, pp 145–149
Kreye VAW, Stiefel A (1983) In vivo and in vitro studies to elucidate the hemodynamic differences of sodium nitroprusside, nitroglycerin, and two isosorbide nitrates. Z Kardiol 72 [Suppl 3]: 52–55
Kreye VAW, Baron GD, Lüth JB, Schmidt-Gayk H (1975) Mode of action of sodium nitroprusside on vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 288: 381–402
Kreye VAW, Kern R, Schleich I (1977) 36 Chloride efflux from noradrenaline-stimulated rabbit arota inhibited by sodium nitroprusside and nitroglycerine. In: Casteels R, Godfraind T, Rüegg JC (eds) Excitation-contraction coupling in smooth muscle. Elsevier/ North-Holland, Amsterdam, pp 145–150
Kukovetz WR, Holzmann S, Wurm A, Poch G (1979) Evidence of cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 310: 129–138
Kukovetz WR, Holzmann S, Poch G (1982) Function of cyclic GMP in acetylcholine-induced contraction of coronary smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 319: 29–33
Kumada T, Gallagher KP, Miller M, McKown M, White F, McKown D, Kemper WS, Ross J Jr (1980) Improvement by isosorbide dinitrate of exercise-induced regional myocardial dysfunction. Am J Physiol 239: H399–H405
Kupper W, Bleifeld W (1980) Effect of nitrates on myocardial blood flow, myocardial lactate extraction and hemodynamics during angina pectoris. In: Rudolph W, Schrey A (eds) Nitrate II. Urban and Schwarzenberg, Munich Vienna Baltimore, p 86
Lacroix P, Linee P, Le Polles JB (1978) Effects of some coronary vasodilator drugs on collateral hemodynamics after chronic myocardial ischemia in the anesthetized dog: Appropriate or inapropriate redistribution? J Pharmacol Exp Ther 204: 645–654
Lange RL, Reid MS, Tresch DD, Keelan MH, Bernhard VM, Coolidge G (1972) Non atheromatous ischemic heart disease following withdrawal from chronic circulation. Circulation 46: 666–678
Laufen H, Scharpf F, Bartsch G (1978) Improved method for the rapid determination of isosorbide dinitrate in human plasma and its application in pharmacokinetic studies. J Chromatography 146: 457–464
Laws CE (1910) Nitroglycerin head. JAMA 54: 793
Lax A, Ceci V, Jacovella G (1977) Effetti stavorevoli dell’isosorbide dinitrato sublinguale- Osservazione su 9 casi personali. G Ital Cardiol 7: 816–817
Lee MG, Fenton-May V (1981) Absorption of isosorbide dinitrate by pvc infusion bags and administration sets. J Clin Hosp Pharm 6: 209–211
Lefer AM, Ogletree ML, Smith JB, Silver MJ, Nicolaou KC, Barnette WE, Gasic GP (1978) Prostacyclin: A potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science 200: 52–54
Leinbach RL, Gold HK (1977) Intermittent and continous nitroglycerin infusions for control of myocardial ischemia. Circulation 56: 194
Leinweber F-J, Melgar MD, Crew MC, DiCarlo FJ (1974) Isolation of pentaerythritol nitrates and their glucuronides. Drug Metab Dispos 2: 40–45
Levin RI, Jaffe EA, Weksler BB, Tack–Goldman K (1981) Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells. J Clin Invest 67: 762–769
Levites R, Bodenheimer MM, Helfant RH (1975) Electrophysiologic effects of nitroglycerin during experimental coronary occlusion. Circulation 52: 1050–1055
Lichtlen P (1976) Die Wirkung von Nitriten und Nitraten auf die links-ventrikulare und koronare Dynamik in Ruhe und wahrend dynamischer Belastung. In: Rudolph W, Sigenthaler W (eds) Nitrate, Wirkung auf Herz und Kreislauf. Urban and Schwarzenberg, Munich Vienna Baltimore, p 80
Lichtlen P, Halter J, Gattiker K (1974) The effect of isosorbiddinitrate on coronary blood flow, coronary resistance and left ventricular dynamics under exercise in patients with coronary artery disease. Basic Res Cardiol 69: 402–421
Lippton HL, Chapnick BM, Hyman AL, Glass FL, Kadowitz PJ (1981) The influence of indomethacin on vasodilator responses to bradykinin and nitroglycerin in the cat. Peptides 2: 165–169
Litvak J, Lambros ES, Vineberg AM (1957) The experimental prodiction of coronary artery insufficiency and occlusion. Am Heart J 53: 505–518
Lund RP, Haggendahl J, Johnsson G (1968) Withdrawal symptoms in workers exposed to nitro-glycerine. Br J Ind Med 25: 136–138
Macho P, Vatner SF (1981) Effects of nitroglycerin and nitroprusside on large and small coronary vessels in conscious dogs. Circulation 64: 1101–1107
Mackenzie JE, Parratt JR (1977) Comparative effects of glyceryl trinitrate on venous and arterial smooth muscle in vitro; relevance to antianginal activity. Br J Pharmacol 60: 155–160
Maier GA, Arena C, Fung HL (1980) Relationship between in vivo nitroglycerin metabolism and in vitro organic nitrate reductase activity in rats. Biochem Pharmacol 29: 646–648
Malindzak GS Jr, Kosinski EJ, Green HD, Yarborough GW (1978) The role of coronary adrenergic receptors in the response to nitroglycerine and the regulation of large and small vessel resistance. Arch Int Pharmacodyn 235: 299–316
Mann T, Cohn PF, Holman BL, Green LH, Markis JE, Phillips DA (1978) Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin. Circulation 57: 732–738
Mansel-Jones D, Taylor T, Doyle E, Chasseaud LF, Darragh A, O’Kelly DA, Over H (1978) Plasma concentrations of isosorbide dinitrate after cutaneous and sublingual doses to human subjects. J Clin Pharmacol 18: 544–548
Marcus CJ, Habig WH, Jakoby WB (1978) Glutathione transferase from human erythrocytes. Arch Biochem Biophys 188: 287–293
Markis JE, Gorlin R, Mills RM, Williams RA, Schweitzer P, Ransil BJ (1979) Sustained effect of orally administered isosorbide dinitrate on excercise performance of patients with angina pectoris. Am J Cardiol 43: 265–271
Marshall JB, Ecklund RE (1980) Methemoglobinemia from overdose of nitroglycerin. JAMA 244: 330
Martin KL, Bohmer H, Rockemann W, Kaltenbach M (1976) Neue Aspekte des Wirkungsmechanismus von Nitroglycerin: Veranderung des Wellenwiderstandes in den herznahen Arterien. Verh Dtsch Ges Inn Med 82: 1123
Mathes P (1975) Kontraktile Eigenschaften koronarwirksamer Nitrate. In: Rudolph W, Siegenthaler W (eds) Nitrate, Wirkung auf Herz und Kreislauf. 1. Nitrat–Symposium, Stockholm 1975. Urban and Schwarzenberg, Munich, p 27
McAnulty JH, Hattenhauer MT, Rosch J, Kloster FE, Rahimtoola SH (1975) Improvement in left ventricular wall motion following nitroglycerin. Circulation 51: 140–145
McNiff EF, Yacobi A, Young-Chang FM, Golden LH, Goldfarb A, Fung HL (1981) Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. J Pharm Sci 70: 1054–1058
Mehta J, Pepine CJ (1978) Effect of sublingual nitroglycerin on regional flow in patients with and without coronary disease. Circulation 58: 803–807
Melgar MD, Leinweber FJ, Crew MC, DiCarlo FJ (1974) Denitration of unconjugated and conjugated pentraerythritol nitrates by rat liver cytosol. Drug Metab Dispos 2: 46–52
Michaelson SP, Batsford WP, Zaret BL (1979) Dissociation of effects of nitroglycerin on regional refractoriness and regional myocardial blood flow following acute coronary occlusion. Cardiovasc Res 13: 407–412
Michel D (1976) Der EinfluB von Metaboliten des Isosorbiddinitrats auf das Belastungs-
EKG bei Koronarinsuffizienz. Herz/Kreisl 8:444–447
Mikkelson E, Andersson KE, Bengtsson B (1978) Effects of verapamil and nitroglycerin on contractile responses to potassium and noradrenaline in isolated human peripheral veins. Acta Pharmacol Toxicol (Copenh) 42: 14–22
Mikolich JR, Nicoloff NB, Robinson PH, Longue RB (1980) Relief of refractory angina with continuous intravenous infusion of nitroglycerin. Chest 77: 375–379
Miller RR, Vismara LA, Williams Do, Amsterdam EA, Mason DT (1976) Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure: Differential effects of nitroprusside, phentolamine and nitroglycerin on cardiac function and peripheral circulation. Circ Res 39: 127–133
Miyazaki H, Masataka I, Yutaka H, Gerl’Ichi I, Yasuhiko F (1982) Simultaneous determination of glyceryl trinitrate and its principal metabolites 1, 2- and 1, 3-glyceryl dinitrate, in plasma by gas chromatography-negative ion chemical ionization-selected ion monitoring. J Chromatogr 239: 277–286
Morcillo E (1980) Responses to arachidonic acid and other dilator agonists and their modification by inhibition of prostaglandin synthesis in the canine hindlimb. J Pharm Pharmacol 32: 340–343
Morcillo E, Reid PR, Dubin N, Ghodgaonkar R, Pitt B (1980) Myocardial prostaglandin E release by nitroglycerin and modification by indomethacin. Am J Cardiol 45: 53–57
Morrison RA, Fung H-L, Hohmann D, Meinertz T, Jahnchen E (1982) Isosorbide dinitrate: pharmacokinetics after intravenous administration. J Pharm Sci 71: 721–723
Morton WE (1977) Occupational habituation to aliphatic nitrates and the withdrawal hazards of coronary disease and hypertension. JOM 19: 197–200
Müller G, Uberbacher JH, Glocke M (1983 b) Koronartherapeutische Wirksamkeit von
niedrig dosiertem IS-5-MN im Vergleich zur Kombination IS-5-MN + Metipranolol und Plazebo. Med Welt 34:321–327
Müller P, Imhof PR, Burkart F, Chu LC, Geradin A (1982) Human pharmacological studies of a new transdermal system containing nitroglycerin. Eur J Clin Pharmacol 22: 473–480
Nakamura M, Nakagaki O, Nose Y, Fukuyama T, Kikuchi Y (1978) Effects of nitroglycerin and dipyridamole on regional myocardial blood flow. Basic Res Cardiol 73: 482–496
Napoli SA, Gruetter CA, Ignarro LJ, Kadowitz RJ (1980) Relaxation of bovine coronary arterial smooth muscle by cyclic GMP, cyclic AMP and analogs. J Pharmacol Exp Ther 212: 469–473
Needleman P (1970) Tolerance to the vascular effects of glyceryl trinitrate. J Pharmacol Exp Ther 171: 98–102
Needleman P, Johnson EM (1973) Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 184: 709–715
Needleman P, Kaley G (1978) Cardiac and coronary prostaglandin synthesis and function. N Engl J Med 298: 1122–1128
Needleman P, Lang S, Johnson EM Jr (1972) Organic nitrates: Relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther 181: 489–497
Needleman P, Jarschik B, Johnson EM (1973) Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther 187: 324–331
Nemerovski M, Shah PK (1981) Syndrome of servere bradycardia and hypotension following sublingual nitroglycerin administration. Cardiology 67: 180–189
Noack E (1982) Pharmakologisehe Basis fur die Therapie mit organischen Nitraten. Herz 7: 275–285
Noer J (1887) Poisonous symptoms from nitroglycerin. Ther Gaz 3: 359
Noonan PK, Benet LZ (1982) Formation of mono- and dinitrate metabolites of nitroglycerin following incubation with human blood. Int J Pharm 12: 331–340
Oberg B, Thoren P (1973) Increased activity in left ventricular receptors during hemorrhage on occlusion of caval veins in the cat; a possible cause of the vaso-vagal reaction. Acta Physiol Scand 87: 121
Oei HH, Hale TH, Kopjas TC, Wegria R (1978) Effect of nitroglycerine on coronary circulation and cardiac metabolism. Arch Int Pharmacodyn 235: 317–327
Ogletree ML, Lefer AM, Smith JB, Nicolaou KC (1979) Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol 56: 95–103
O’Hara MJ, Bowles MJ, Khurmi NS, Subramanian YB, Raftery EB (1983) A new mode of nitrate therapy for angina pectoris. Abstract 119, I I. World conference on clinical pharmacology and therapeutics, Washington, D. C.
Ohlendorf R, Perzborn E, Schroter K (1980) Prevention of infarction-induced decrease in
circulating pletelet count by prostacyclin. Thromb Res 19:447–453
Ohlstein EH, Wood KS, Ignarro LJ (1982) Purification and properties of heme-deflcient hepatic soluble guanylate cyclase: Effects of heme and other factors on enzyme activation by NO, NO-heme and protoprophyrin IX. Arch Biochem Biophys 218: 187–198
Opherk D, Maurer W, Mehmel HC, Zebe H, Kiibler W (1977) Koronardurchblutung, myokardialer 02-Verbrauch und linksventrikulare Funktion nach sublingualer Applikation von Isosorbiddinitrat. Verh Dtsch Ges Inn Med 83: 207–208
Osterspey A, Jansen W, Ulbrich T, Simon P, Tauchert M, Hilger HH (1984) Wirkung von Nitroglyzerinpflastern auf Hamodynamik und Belastbarkeit von Patienten mit koronarerHerzkrankheit. MMW 18: 714–717
Parker JC, DiCarlo FJ, Davidson IWF (1975) Comparative vasodilator effects of nitroglycerin, pentaerythritol trinitrate and biometabolites and other organic nitrates. Eur J Pharmacol 31: 29–37
Parmley WW, Chatterjee K (1978) Vasodilator therapy. Curr Probl Cardiol 2: 66–70
Paz LR de la, Kerigan AT, Koch GG, Kolman WA, Spodick DH (1979) Erythrityl tetranitrate: sustained effects on systolic time intervals. Changes consistent with sustained preload reduction. Am J Med Sci 277: 173–177
Pepine CJ, Feldman RL, Conti CR (1982) Action of intracoronary nitroglycerin in refractory coronary artery spasm. Circulation 65: 411–414
Pinkus LM, Ketley JN, Jakoby WB (1977) The glutathione-s-transferase as possible detoxification system of rat intestinal epithelium. Biochem Pharmacol 26: 2359–2363
Platzer R, Reutemann G, Galeazzi RL (1982) Pharmacokinetics of intravenous isosorbidedinitrate. J Pharmacokinet Biopharm 10: 575–585
Plotnick GD (1979) Approach to the management of unstable angina. Am Heart J 98: 243–255
Poliner LR, Ritter W, Wohl AJ, Nixon JY, Willerson JT (1977) Hemodynamic effects of oral and sublingual form of isosorbide dinitrate in patients with acute coronary insufficiency. Tex Med 73: 53–58
Porchet H, Bircher J (1982) Noninvasive assessment of portalsystemic shunting: Evaluation of a method to investigate systemic availability of oral glyceryl trinitrate by digital plethysmography. Gastroenterology 82: 629–637
Posadas del Rio AF (1973) Glutathione-organic nitrate reductase in mammalian tissues: Purification and characterization. Dissertation, Washington University, St Louis
Prodger SH, Ayman D (1932) Harmful effects of nitroglycerin with special reference to coronary thrombosis. Am J Med Sci 184: 480–491
Rafflenbeul W, Urthaler F, Russel RO, Lichtlen P, James TN (1980) Dilatation of coronary artery stenoses after isosobide dinitrate in man. Br Heart J 43: 91–97
Reed DE, Akester JM, Prather JF, Tuckosh JR, McCurdy DH, Yeh C (1977) Blood and tissue levels of [14C]isosorbide dinitrate after oral and intravenous administration to rat. J Pharmacol Exp Ther 202: 32–37
Rees JR, Redding VJ, Ashfield R, Gibson D, Gavey CJ (1966) Myocardial blood flow measurement with 133xenon effect of glyceryl trinitrate. Br Heart J 28: 374–381
Reichek N, Goldstein RE, Redwood DR, Epstein StE (1974) Sustained effects of nitroglycerin ointment in patients with angina pectoris. Circulation 50: 348–352
Rich S, Ford LE, Al-Sadir J (1980) The angiographic effect of ergonovine and nifedipine in coronary artery spasm. Circulation 62: 1127–1130
Romeril KR, Concannon AJ (1981) Heinz body haemolytic anaemia after sniffing volatile
nitrites. Med J Aust 1:302–303
Rudolph W, Blasini R, Reiniger G (1983) Tolerance development during isosorbide dinitrate treatment: Can it be circumvented? Z Kardiol 72, Suppl 3: 195–198
Rush ML, Lang WJ, Rand MJ (1971) Studies on compensatory reflexes and tolerance to glyceryl trinitrate ( GTN ). Eur J Pharmacol 16: 148–155
Rutsch W, Schmutzler H (1981) Left ventricular function and regional wall motion after intracoronary application of nitrates in coronary heart disease. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 134
Salem HH, Singh SP (1979) Glyceryl trinitrate ointment in angina pectoris. Postgrad Med J 55: 874–876
Salerno JA, Previtali M, Medici A, Chimienti M, Bramucci E, Lepore R, Specchia G, Bobba P (1981) Treatment of vasospastic angina pectoris at rest with nitroglycerin ointment: A short-term controlled study in the coronay care unit. Am J Cardiol 47: 1128–1133
Sausker WF, Frederick FD (1978) Allergic contact dermatitis secondary to topical nitroglycerin. JAMA 239: 1732–1744
Schafer Al, Handin RI (1979) The role of platelets in thrombotic and vascular disease. Prog Cardiovasc Dis 22: 31–52
Schelling JL, Lasagna L (1966) A study of cross-tolerance to circulatory effects of organic nitrates. Clin Pharmacol Ther 8: 256–260
Schinz A, Schnelle K, Klein G (1978) Hemodynamik effects of cutaneously administered isosorbide dinitrate ointment. Int J Clin Pharmacol 16: 297–301
Schlup P, Zatti C, Studer H (1980) Toleranzentwicklung gegeniiber den hamodynamischen Wirkungen von Nitroglycerin. Schweiz Med Wochenschr 110: 1927–1930
Schneider W, Stahl B, Kaltenbach M, Bussmann W-D (1982) Dosiswirkungsbeziehung bei der Behandlung der Angina pectoris mit Isosorbiddinitrat. Dtsch Med Wochenschr 107: 771–776
Schror K, Grodzinska L, Darius H (1981 a) Stimulation of coronary vascular prostacyclin
and inhibition of human platelet thromboxane A2 after low-dose nitroglycerin. Thromb Res 23:59–67
Schror K, Addicks K, Darius H, Ohlendorf R, Rosen P ( 1981 b) PGI2 inhibits ischemiainduced platelet activation and prevents myocardial damage by inhibition of catecholamine release from adrenergic nerve terminals. Evidence for cAMP as common denominator. Thromb Res 21: 175–180
Schultz K-D, Schultz K, Schultz G (1977) Sodium nitroprusside and other smooth musclerelaxants increase cyclic GMP levels in rat ductus deferens. Nature 265: 750–751
Schulz V, Jansen W, Pohler E, Tauchert R (1982) Toleranz gegen Nitroglyzerin bei mehrtagiger intravenoser Infusion. Verh Dtsch Ges Inn Med 88: 669–672
Schwartz AM (1946) The cause, relief and prevention of headaches arising from contract with dynamite. Engl J Med 235: 541–544
Schwarzer CH, Mlczoch J (1982) Zur Frage der Toleranzentwicklung von Isosorbid-5-Mononitrat. Herz 14: 585–589
Seidel F, Michel D (1980) Comparative haemodynamic and pharmacokinetic investigations after oral isosorbide-2-mononitrate and isosorbide 5-mononitrate. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 54
Senges J, Zebe H, Pelzer D, Brachmann J, Kramer B, Kiibler W (1979) Nitrates and ectopic ventricular activity in mitral valve prolapse: Clinical and experimental data. Z Kardiol 68: 26–31
Shane SJ, Iazzetta JJ, Chisholm AW, Berka JF, Leung D (1978) Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man. Br J Clin Pharmacol 6: 37–41
Sharma B, Hodges M, Asinger RW, Goodwin JF, Francis GS (1980) Left ventricular function during spontaneous angina pectoris: Effect of sublingual nitroglycerin. Am J Cardiol 46: 34–41
Sherf L, Bon-Shaul Y, Lieberman Y, Neufeld HN (1977) The human coronary microcirculation: an electron microscopic study. Am J Cardiol 39: 599
Shesser R, Dixon D, Allen Y, Mitchell J, Edelstein S (1980) Fatal methemoglobinemia from butyl nitrite ingestion. Ann Intern Med 92: 131–132
Short RD, Dacre JC, Lee C-C (1977) A species and developmental comparison of trinitroglycerin metabolism in vitro. Biochemical Pharmacol 26: 162–163
Simon R, Amende I, Hood WP, Lichtlen PR (1980) Effect of nitroglycerin on diastolic and systolic left ventricular function in normals and patients with coronary artery disease. In: Rudolph W, Schrey A (eds) Nitrate II. Urban and Schwarzenberg, Munich, p 183
Simon R, Amende I, Lichtlen PR (1981) Effects of nitroglycerin on blood velocity and flow in coronary arteries and bypass grafts in man. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 202
Simonetti I, de Caterina R, Marzilli M, de Nes M, FAbbate A (1983) Coronary vasodilation by nitrates is not mediated by the prostaglandin system: an angiographic and hemodynamic study Z Kardiol 72 [Suppl 3]:4(M5
Sprague HB, White PD (1933) Nitroglycerin collapse - a potential danger in therapy. Report
of three cases. Med Clin North Am 16:859–898
Stauch M, Grewe N (1980) Die Wirkung von Isosorbiddinitrat, Isosorbid-2- und 5-Mononitrat auf das Belastungs-EKG und auf die Hamodynamik wahrend Vorhofstimulation bei Patienten mit Angina pectoris. In: Rudolph W, Schrey A (eds) Nitrate II. Urban and Schwarzenberg, Munich, p 378
Stauch M, Grewe N, Nissen H (1975) Die Wirkung von 2- und 5-Isosorbidmononitrat auf das Belastungs-EKG von Patienten mit Koronarinsuffizienz. Verh Dtsch Ges Kreislaufforseh 41: 182–184
Steele RJ, Burggraf GW, Parker JO (1975) Effects of isosorbide dinitrate on the response to atrial pacing in coronary heart disease. Am J Cardiol 36: 206–210
Steele PP, Rainwater J, Jensen D, Vogel RA, Battock D (1978) Isosorbide dinitrate-induced
improvement in left ventricular ejection fraction during exercise in coronary arterial disease. Chest 74:526–529
Stein RL, O’Brian JK, Irwin C, Townsend-Parchman JK, Hunter FE Jr (1980) Extension of the blood half-life of glyceryl trinitrate. Inhibition of glutathione organic nitrate ester reductase activity in the rat and guinea pig. Biochem Pharmacol 29: 1807–1813
Steiner RW, Manoguerra AS (1980) Butyl nitrite and methemoglobinemia. Ann Intern Med 92: 570–571
Stewart DD (1905) Tolerance to nitroglycerin. JAMA 44: 1678–1679
Stipe AA, Fink GB (1973) Prophylactic therapy of angina pectoris with organic nitrates. Relationship of drug efficacy and clinical experimental design. J Clin Pharmacol 13: 244–250
Strauer BE (1975) Pharmakodynamik - Inotrope Wirkung von Nitraten am isolierten Ventrikelmyokard. In: Rudolph W, Siegenthaler W (eds) Nitrate I. Urban and Schwarzenberg, Munich, p 21
Strauer BE, Scherpe A (1978) Ventricular function and coronary hemodynamics after intravenous nitroglycerin in coronary artery disease. Am Heart J 95 /2: 210–219
Strein K, Heboid G, Czerwek H, Bartsch W (1982) Differences in toxicity of isosorbide dinitrate and isosorbide 5-mononitrate ( Abstr ). Naunyn Schmiedebergs Arch Pharmacol [Suppl] 319: 76
Strein K, Bartsch W, Sponer G, Müller-Beckmann B, Lexa P (1984) Differences in the nitrite
ion formation and the toxicological findings between isosorbide dinitrate and isosorbide-5-mononitrate. Toxicol Appl Pharmacol 72:142–147
Strohm WD, Rahn R, Cordes H-J, Kurtz W, Kober G (1983) Diameters of abdominal veins and arteries during nitrate therapy. Z Kardiol 72 [Suppl 3]: 56–61
Swain JL, Parker JP, McHale PA, Greenfield JC Jr (1979) Effects of nitroglycerin and propranolol on the distribution of transmural myocardial blood flow during ischemia in the absence of hemodynamic changes in the unanesthetized dog. J Clin Invest 63: 947–953
Symanski H (1952) Schwere Gesundheitsschadigungen durch berufliche Nitroglykoleinwirkung. Arch Hyg Bakteriol 136:139 ff
Szekeres L, Voghy P, Bor P, Csete K (1978) Possible mode of action of nitroglycerin on heart mitochondria. Recent Adv Stud Cardiac Struct Metab 11: 495
Taylor T, O’Kelly DA, Major RM, Darragh A, Chasseaud LF (1978) Plasma concentrations of isosorbide dinitrate after administration of increasing doses of a sustainedrelease formulation to human subjects. Arzneimittelforsch 28: 1426–1428
Taylor T, Chasseaud LF, Doyle E (1980) Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects. Biopharm Drug Dispos 2: 149–156
Taylor T, Chasseaud LF, Major R, Doyle E (1981) Isosorbide-5-mononitrate pharmacokinetics in humans. Biopharm Drug Dispos 2: 255–263
Taylor T, Chasseaud LF, Doyle E, Bonn R, Darragh A, Lambe RF (1982) Isosorbide dinitrate pharmacokinetics. Arzneimittelforsch 32: 1329–1333
Thadani U, Kellerman D (1983) Interaction of indomethacin and nitroglycerin on hemodynamics and exercise tolerance in patients with angina pectoris. Z Kardiol 72 [Suppl 3]: 3 5–39
Thadani U, Darke AC, Fung HL, Parker JO ( 1980 a) Dose response and duration of action of oral isosorbide dinitrate ( ISDN) during sustained therapy in angina pectoris. Am J Cardiol 45: 478
Thadani U, Fung HL, Darke AC, Parker JO ( 1980 b) Oral isosorbide dinitrate in the treatment of angina pectoris. Dose response relationship and duration of action during acute therapy. Circulation 62: 491–502
Thadani U, Manyari D, Parker JO, Fung HL ( 1980 c) Tolerance to the circulatory effects of oral isosorbide dinitrate. Its rate of development and cross tolerance to glyceryl trinitrate. Circulation 61: 526–535
Thadani U, Fung HL, Darke AC, Parker JO (1982) Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose–response relation during acute and sustained therapy. Am J Cardiol 49: 411–419
Thompson RH (1983) The clinical use of transdermal delivery–devices with nitroglycerin. Angiology 34: 23–31
Thoren PN, Donald DE, Shephard JT (1976) Role of heart and lung receptors with nonmedullated vagal afferent in circulatory control. Circ Res 38: 2–9
Tillmanns H, Steinhausen M, Leinberger H, Thederan H, Jauernig R, Kubler W (1981) Different effects of intracoronary and intravenous administration of nitroglycerin on the microcirculation of the ventricular myocardium of the cat and rat heart. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds) Nitrates III. Springer, Berlin Heidelberg New York, p 141
Uberbacher HJ, Steinorth G, Glocke M, Abshagen U (1983) An open, long-term, multicenter study of the antianginal efficacy and safety of isosorbide-5-mononitrate at low doses in patients with coronary heart disease. Pharmatherapeutica 3: 331–341
Vatner SF, Heyndrickx GR (1975) Mechanism of action of nitroglycerin: coronary, cardiac and systemic effects. In: Neddleman P (ed) Organic nitrates. Springer, Berlin Heidelberg New York, pp 131–161 (Handbook of experimental pharmacology, vol 40 )
Vatner SF, Pagani M, Rutherford JD, Millard RW, Manders WT (1978) Effects of nitroglycerin on cardiac function and regional blood flow distribution in conscious dogs. Am J Physiol 234: 244–252
Vatner SF, Pagani M, Manders WT, Pasipoularides AD (1980) Alpha adrenergic vasoconstriction and nitroglycerin vasodilation of large coronary arteries in the conscious dog. J Clin Invest 65: 5–14
Vohra J, Baker G, Ross D, Hunt D, Sloman G (1979) Duration of action of pentaerythritol trinitrate and nitroglycerine: a comparison using exercise performance and haemodynamic alterations. Aust NZ J Med 9: 554–560
Volkmer F, Hochrein H (1977) Wirkung von Retard-Nitroglycerin auf den Pulmonalarteriendruck bei koronarer Herzkrankheit. Dtsch Med Wochenschr 102: 1458–1460
Wastila WB, Namm DH, Maxwell RA (1976) Comparison of the vascular effects of serveral organic nitrates in anesthetized rats and dogs after intravenous and intraportal administration. In: Bevan JA, Burnstock G, Johansson B, Needergaard OA (eds) Vascular neuroeffector mechanismus. 2nd international symposium, Odense 1975. Karger, Basel, pp 216–225
Wei JY, Reid PR (1981) Relation of time course of plasma nitroglycerin levels to echocardiographic, arterial pressure and heart rate changes after sublingual administration of nitroglycerin
nitroglycerin. Am J Cardiol 48:778–782
Wendt RL (1972) Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide. J Pharmacol Exp Ther 180: 732–742
Wilkes SB, Howe BB, Winbury MM (1975) Pentaerythritol trinitrate and glyceryl trinitrate on myocardial oxygen consumption and haemodynamics in the dog. Clin Exp Pharmacol Physiol 2: 517–528
Wilkinson CJ, Sanders JH (1980) Massive doses of nitroglycerin in a patient with variant angina. Anesth Analg (Cleve) 59: 707–709
Wille HH, Sauer G, Tebbe U, Neuhaus KL, Kreuzer H (1980) Nitroglycerin and afterload: effects of aortic compliance and capacity of the Windkessel. Eur Heart J 1: 445–542
Willis WH, Russell RO, Mantle JA, Ratshin RA, Rackley CE (1976) Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable angina. Chest 69: 15–21
Winbury MM (1964) Experimental approaches to the development of antianginal drugs. In: Garattini S, Shore PA (eds) Advances in pharmacology, vol 3. Academic, New York, pp 1–82
Winbury MM, Howe BB, Hefner MA (1969) Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates. J Pharmacol Exp Ther 168: 70–95
Winsor T, Berger HJ (1975) Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic and statistical evidence of efficacy based on a three-phase experimental design. Am Heart J 90: 611–626
Winsor T, Kaye H, Mills B (1972) Hemodynamic response of oral long-acting nitrates: evidence of gastrointestinal absorption. Chest 62: 407–413
Wolf R, Beck OA, Guhl E, Hochrein H (1976) Hamodynamische und elektrokardiographische Langzeit-Nitratwirkung unter Frequenzbelastung bei koronarer Herzkrankheit. Z Kardiol 65: 435–444
Zelis R, Mason DT (1975) Isosorbide dinitrate. Effect on the vasodilator response to nitroglycerin. JAMA 234: 166–170
Zsoter TT, Henein NF, Wolchinsky C (1977) The effect of sodium nitroprusside on the uptake and efflux of 45Ca from rabbit and rat vessels. Eur J Pharmacol 45: 7–12
Editor information
Editors and Affiliations
Additional information
Dedicated with gratitude to Professor Dr. Helmut Kewitz on the occasion of his 65th birthday
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Abshagen, U. (1985). Organic Nitrates. In: Abshagen, U. (eds) Clinical Pharmacology of Antianginal Drugs. Handbook of Experimental Pharmacology, vol 76. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69524-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-69524-7_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69526-1
Online ISBN: 978-3-642-69524-7
eBook Packages: Springer Book Archive